{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:47:51Z","timestamp":1792594071165,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011503","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000}}],"reference-count":49,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011503.pub2","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T14:45:06Z","timestamp":1479307506000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients"],"prefix":"10.1002","volume":"2016","author":[{"given":"Alexander K","family":"Schuster","sequence":"first","affiliation":[{"name":"University Medical Center Mainz; Department of Ophthalmology; Langenbeckstr. 1 Mainz Germany 55131"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn C","family":"Harder","sequence":"additional","affiliation":[{"name":"Medical Faculty Mannheim, Heidelberg University; Department of Ophthalmology; Theodor-Kutzer-Ufer 1-3 Mannheim Germany 68167"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C","family":"Schlichtenbrede","sequence":"additional","affiliation":[{"name":"Medical Faculty Mannheim, Heidelberg University; Department of Ophthalmology; Theodor-Kutzer-Ufer 1-3 Mannheim Germany 68167"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N","family":"Jarczok","sequence":"additional","affiliation":[{"name":"Heidelberg University; Building 4041, 3. OG, Room 306 Heidelberg Germany 69115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Tesarz","sequence":"additional","affiliation":[{"name":"Heidelberg University; Department of General Internal Medicine and Psychosomatics, Medical Hospital; Im Neuenheimer Feld 410 Heidelberg Germany 69120"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"key":"10.1002\/14651858.CD011503.pub2-BIB0001|cit1","unstructured":"Cochener B Hoang-Xuan T Rolland B Colin J A double blind randomized trial to compare safety and efficacy of valaciclovir and aciclovir for treatment of herpes zoster ophthalmicus Investigative Ophthalmology and Visual Science 1997 ARVO E-Abstract 965"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0002|cit2","unstructured":"Colin J Cochener B Lescale O Hannouche D Hoang-Xuan T Treatment of herpes zoster ophthalmicus: a double-blind trial to compare valaciclovir and aciclovir American Academy of Opththalmology 1997 170"},{"issue":"8","key":"10.1002\/14651858.CD011503.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0161-6420(00)00222-0","article-title":"Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus","volume":"107","author":"Colin","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0004|cit4","first-page":"3","article-title":"Valacyclovir","volume":"38","author":"Anonymous","year":"1996","journal-title":"Medical Letter on Drugs and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011503.pub2-BIB0005|cit5","first-page":"189","article-title":"Randomized, open, comparative, multicentric, pilot study on the efficacy and tolerability of peroral valacyclovir and acyclovir in patients with genital herpes and varicella zoster virus infections","volume":"24","author":"Barsic","year":"2004","journal-title":"Infektoloski Glasnik"},{"issue":"10","key":"10.1002\/14651858.CD011503.pub2-BIB0006|cit6","first-page":"20","article-title":"New zoster treatment. Can aciclovir be improved?","volume":"5","author":"Bell","year":"1996","journal-title":"Chemotherapie Journal"},{"issue":"7","key":"10.1002\/14651858.CD011503.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD011503.pub2-BIB0008|cit8","first-page":"50","article-title":"Prospects for improved efficacy with antiviral prodrugs: Will valaciclovir and famciclovir meet the clinical challenge?","volume":"2","author":"Carrington","year":"1994","journal-title":"International Antiviral News"},{"issue":"4","key":"10.1002\/14651858.CD011503.pub2-BIB0009|cit9","first-page":"537","article-title":"Comparative study of treatment of herpes zoster with valaciclovir and acyclovir","volume":"27","author":"Chen","year":"2006","journal-title":"Wuhan Daxue Xuebao (Yixue Ban)"},{"issue":"6","key":"10.1002\/14651858.CD011503.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0885-3924(02)00393-7","article-title":"Clinical applications for change-point analysis of herpes zoster pain","volume":"23","author":"Desmond","year":"2002","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD011503.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/j.1875-9114.1997.tb03716.x","article-title":"Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model","volume":"17","author":"Grant","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD011503.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00006454-199709000-00004","article-title":"Generic acyclovir vs. famciclovir and valacyclovir","volume":"16","author":"Grose","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD011503.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11910-002-0032-3","article-title":"Valacyclovir and famciclovir therapy in herpes zoster","volume":"2","author":"Jubelt","year":"2002","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"6","key":"10.1002\/14651858.CD011503.pub2-BIB0014|cit14","first-page":"Inside back cov","article-title":"Effect of valociclovir hydrochloride on patients with herpes zoster","volume":"24","author":"Li","year":"1999","journal-title":"Bulletin of Hunan Medical University"},{"issue":"2","key":"10.1002\/14651858.CD011503.pub2-BIB0015|cit15","first-page":"138","article-title":"Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster","volume":"34","author":"Lin","year":"2001","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"issue":"1","key":"10.1002\/14651858.CD011503.pub2-BIB0016|cit16","first-page":"43","article-title":"A randomised controlled trial of valaciclovir versus acyclovir in the treatment of 100 patients with herpes zoster","volume":"29","author":"Liu","year":"2000","journal-title":"Journal of Clinical Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011503.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/514271","article-title":"Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain","volume":"178","author":"Wood","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011503.pub2-BIB0018|cit18","first-page":"288","article-title":"A randomised controlled trial of valaciclovir versus acyclovir in the treatment of herpes zoster","volume":"29","author":"Xu","year":"2000","journal-title":"Journal of Clinical Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011503.pub2-BIB0019|cit19","first-page":"21","article-title":"Comparison between the efficacies of valaciclovir and acyclovir in the treatment of herpes zoster","volume":"20","author":"Yan","year":"1999","journal-title":"Shanghai Medicine"},{"issue":"7066","key":"10.1002\/14651858.CD011503.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD011503.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/586903","article-title":"Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older","volume":"197","author":"Arora","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011503.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0023|cit23","unstructured":"Cochener B Hoang-Xuan T Rolland B Colin J A double blind randomized trial to compare safety and efficacy of valaciclovir and aciclovir for treatment of herpes zoster ophthalmicus Investigative Ophthalmology and Visual Science 1997 ARVO E-Abstract 965"},{"issue":"3","key":"10.1002\/14651858.CD011503.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","article-title":"Clinical practice: Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0025|cit25","unstructured":"Colin J Cochener B Lescale O Hannouche D Hoang-Xuan T Treatment of herpes zoster ophthalmicus: a double-blind trial to compare valaciclovir and aciclovir American Academy of Opththalmology 1997 170"},{"issue":"1","key":"10.1002\/14651858.CD011503.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0706446","article-title":"Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy","volume":"147","author":"Clercq","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011503.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011503.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD011503.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.ophtha.2006.05.063","article-title":"Primary treatment of acute retinal necrosis with oral antiviral therapy","volume":"113","author":"Emerson","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011503.pub2-BIB0030|cit30","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"1","key":"10.1002\/14651858.CD011503.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0022-3565(24)38156-X","article-title":"Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line","volume":"289","author":"Guo","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0032|cit32","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"issue":"3","key":"10.1002\/14651858.CD011503.pub2-BIB0033|cit33","first-page":"177","article-title":"Herpes zoster guideline of the German Dermatology Society (DDG)","volume":"26","author":"Gross","year":"2003","journal-title":"Journal of Clinical Virology"},{"issue":"11","key":"10.1002\/14651858.CD011503.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0035|cit35","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD011503.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2007.11.016","article-title":"Vitreous penetration of orally administered valacyclovir","volume":"145","author":"Huynh","year":"2008","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0037|cit37","volume-title":"Klinische Ophthalmologie","author":"Kanski","year":"2008"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Krikham","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD011503.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3851\/IMP2011","article-title":"Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials","volume":"17","author":"McDonald","year":"2012","journal-title":"Antiviral Therapy"},{"issue":"10","key":"10.1002\/14651858.CD011503.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008770","article-title":"Management of herpes zoster ophthalmicus in people with HIV infection","author":"Olusanya","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011503.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2165\/00003495-200059060-00009","article-title":"Valaciclovir: a review of its use in the management of herpes zoster","volume":"59","author":"Ormrod","year":"2000","journal-title":"Drugs"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011503.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ophtha.2007.10.012","article-title":"Herpes zoster antivirals and pain management","volume":"115","author":"Pavan-Langston","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011503.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2165\/00003495-199652050-00009","article-title":"Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections","volume":"52","author":"Perry","year":"1996","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/14651858.CD011503.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0045|cit45","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011503.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2415-12-48","article-title":"Valacyclovir in the treatment of acute retinal necrosis","volume":"12","author":"Taylor","year":"2012","journal-title":"BMC Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011503.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archopht.1983.01040010044004","article-title":"Complications of herpes zoster ophthalmicus","volume":"101","author":"Womack","year":"1983","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011503.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011503","article-title":"Valaciclovir versus aciclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients","author":"Schuster","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011503.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T12:55:21Z","timestamp":1749732921000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011503.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011503.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,14]]}}}